Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Friday, July 19, 2019Mallinckrodt plc a global biopharmaceutical company and Silence Therapeutics plc a leader in the discovery development and delivery of novel RNA interference RNAi therapeutics for the treatment of serious diseases today announced a collaboration tha...
Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
Friday, July 19, 2019Boehringer Ingelheim and Bridge Biotherapeutics Inc today announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge Biotherapeuticss autotaxin inhibitor BBT for patients with fibrosing intersti...
PureTech Acquires New Clinical-Stage Program LYT-100 to Treat Lymphedema
Thursday, July 18, 2019PureTech Health plc an advanced biopharmaceutical company developing novel medicines for dysfunctions of the BrainImmuneGut BIG axis today announced it has acquired and plans to develop a clinicalstage product candidate for the potential treatment of...
Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology
Thursday, July 18, 2019Anixa Biosciences Inc a biotechnology company focused on harnessing the bodys immune system to fight cancer today announced that it has established a strategic alliance and license agreement with Cleveland Clinic for an innovative breast cancer vacci...
Convelo Therapeutics Enters Into Collaboration and Option to Acquire Agreement With Genentech to Discover Novel Remyelinating Therapies
Wednesday, July 17, 2019Convelo Therapeutics Inc a biotechnology company with a mission to discover a new class of medicines that regenerate the protective myelin coating around nerve cells has entered into an exclusive worldwide collaboration with Genentech a member of the...
Epistem licence Hubrecht Organoid Technology to expand pre-clinical toxicology service portfolio
Wednesday, July 17, 2019Epistem Limited the UK based preclinical and clinical research services company announces the expansion of its in vitro model portfolio by the completion of an agreement with Hubrecht Organoid Technology HUB to enable the delivery of an increased ran...
AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
Tuesday, July 16, 2019AbbVie announced today that it has acquired Seattlebased Mavupharma a privately held biopharmaceutical company focused on novel approaches to target the STING STimulator of INterferon Genes pathway for the treatment of cancer
Hoth Therapeutics, Inc. Expands Working Relationship with the George Washington University and Enters Exclusive License Option Agreement
Tuesday, July 16, 2019Hoth Therapeutics Inc a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitisalso known as eczemaas well as dermatological and chronic wound disorders today announced that...
Sun Pharma Launches Ezallor Sprinkle (Rosuvastatin) in the U.S. for People Who Have Difficulty Swallowing
Monday, July 15, 2019Sun Pharmaceutical Industries Ltd today announced the US launch of Ezallor Sprinkle rosuvastatin capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing a problem that is estimated to affect appr...
Gilead and Galapagos Enter Into Transformative Research and Development Collaboration
Monday, July 15, 2019Gilead Sciences Inc and Galapagos NV announced that they have entered into a year global research and development collaboration Through this agreement Gilead will gain access to an innovative portfolio of compounds including six molecules currently
